FDA 483 - Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.) - January 12, 2024

The document content could not be processed for summarization. The provided input indicates that all PDF extraction methods failed, and the Tesseract OCR process timed out. Therefore, I cannot extract the company name, inspection dates, main violations, regulatory framework, or required actions to create the requested summary of the FDA 483 document.